Toby C Trujillo Selected Research

Toby C Trujillo Research Topics

Disease

8	Hemorrhage 02/2022 - 12/2012
6	Thrombocytopenia (Thrombopenia) 02/2022 - 05/2010
5	Venous Thromboembolism 08/2022 - 05/2010
3	Atrial Fibrillation 08/2022 - 09/2018
2	Body Weight (Weight, Body) 08/2022 - 02/2022
2	COVID-19 02/2022 - 11/2020
2	Thrombosis (Thrombus) 02/2022 - 08/2010
2	Myocardial Infarction 10/2020 - 12/2007
2	Acute Coronary Syndrome 10/2020 - 12/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2012 - 04/2012
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2020
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2019
1	Embolism (Embolus) 09/2018
1	Stroke (Strokes) 09/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2016
1	Pulmonary Embolism 01/2016
1	Neoplasms (Cancer) 11/2014
1	Critical Illness (Critically Ill) 03/2011
1	Rupture 08/2010
1	Atherosclerotic Plaque (Atheroma) 08/2010
1	ST Elevation Myocardial Infarction 08/2010
1	Obesity 05/2010
1	Disease Progression 12/2007
1	Stable Angina 12/2007
1	Ischemia 10/2006
1	Torsades de Pointes (Torsade de Pointes) 10/2006
1	Pain (Aches) 07/2006
1	Confusion (Bewilderment) 07/2006
1	Fatigue 06/2005
1	Fever (Fevers) 06/2005
1	Chest Pain (Chest Pains) 06/2005
1	Chills 06/2005
1	Acute Kidney Injury (Acute Renal Failure) 06/2005

Drug/Important Bio-Agent (IBA)

13	AnticoagulantsIBA 08/2022 - 05/2010
5	Heparin (Liquaemin)FDA LinkGeneric 02/2022 - 05/2010
3	Vitamin K FDA Link 12/2019 - 09/2018
3	Pharmaceutical PreparationsIBA 01/2019 - 10/2006
2	Dabigatran FDA Link 08/2022 - 01/2019
2	apixabanIBA 08/2022 - 01/2019
2	edoxabanIBA 08/2022 - 01/2019
2	RivaroxabanIBA 08/2022 - 01/2019
2	Warfarin (Coumadin)FDA LinkGeneric 08/2022 - 01/2019
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2020 - 12/2007
2	AntithrombinsIBA 02/2020 - 03/2011
2	argatroban (MPQA)FDA Link 02/2020 - 03/2011
2	Ranolazine FDA Link 12/2007 - 10/2006
1	Biomarkers (Surrogate Marker)IBA 02/2022
1	SolutionsIBA 11/2021
1	PRT064445IBA 01/2021
1	Factor Xa (Coagulation Factor Xa)IBA 01/2021
1	Prothrombin (Factor II)IBA 01/2021
1	Factor Xa InhibitorsIBA 01/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2020
1	TicagrelorIBA 10/2020
1	bivalirudin (Angiomax)FDA Link 02/2020
1	Blood Coagulation Factors (Coagulation Factor)IBA 12/2019
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2014
1	Proton Pump InhibitorsIBA 12/2012
1	Clopidogrel (Plavix)FDA Link 12/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2012
1	CholesterolIBA 04/2012
1	CarbohydratesIBA 04/2012
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2007
1	NitratesIBA 12/2007
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 12/2007
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2007
1	SodiumIBA 10/2006
1	CalciumIBA 10/2006
1	EnzymesIBA 07/2006
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 07/2006
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 07/2006
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 07/2006
1	Intravenous Immunoglobulins (IVIG)FDA Link 06/2005
1	SugarsIBA 06/2005
1	Excipients (Suspending Agents)IBA 06/2005

Therapy/Procedure

7	Therapeutics 11/2020 - 08/2010
2	Percutaneous Coronary Intervention 10/2020 - 12/2012
1	Extracorporeal Membrane Oxygenation 02/2022
1	Artificial Respiration (Mechanical Ventilation) 02/2022
1	Critical Care (Surgical Intensive Care) 11/2020
1	Thrombolytic Therapy 11/2020
1	Length of Stay 10/2020
1	Catheter Ablation 01/2019
1	Electric Countershock (Cardioversion) 01/2019
1	Catheters 05/2010
1	Drug Therapy (Chemotherapy) 12/2007